Alterations in succinate dehydrogenase (SDH), tuberous sclerosis (TSC) and fructose-1,6-bisphosphatase 1 (FBP1) represent additional lesions that drive metabolic reprogramming in kidney cancer32. Here, FBP1 is linked to tuberous sclerosis.